Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Net Income: 2019-2024

Historic Net Income for GeneDx Holdings (WGS) over the last 6 years, with Dec 2024 value amounting to -$52.3 million.

  • GeneDx Holdings' Net Income rose 8.14% to -$7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 102.50%. This contributed to the annual value of -$52.3 million for FY2024, which is 70.25% up from last year.
  • Latest data reveals that GeneDx Holdings reported Net Income of -$52.3 million as of FY2024, which was up 70.25% from -$175.8 million recorded in FY2023.
  • GeneDx Holdings' Net Income's 5-year high stood at -$52.3 million during FY2024, with a 5-year trough of -$548.9 million in FY2022.
  • Moreover, its 3-year median value for Net Income was -$175.8 million (2023), whereas its average is -$259.0 million.
  • Per our database at Business Quant, GeneDx Holdings' Net Income plummeted by 712.48% in 2020 and then spiked by 70.25% in 2024.
  • Yearly analysis of 5 years shows GeneDx Holdings' Net Income stood at -$241.3 million in 2020, then declined by 1.68% to -$245.4 million in 2021, then plummeted by 123.70% to -$548.9 million in 2022, then spiked by 67.98% to -$175.8 million in 2023, then skyrocketed by 70.25% to -$52.3 million in 2024.